143 related articles for article (PubMed ID: 29632639)
1. Reduced expression of α-L-Fucosidase-1 (FUCA-1) predicts recurrence and shorter cancer specific survival in luminal B LN+ breast cancer patients.
Bonin S; Parascandolo A; Aversa C; Barbazza R; Tsuchida N; Castellone MD; Stanta G; Vecchio G
Oncotarget; 2018 Mar; 9(20):15228-15238. PubMed ID: 29632639
[TBL] [Abstract][Full Text] [Related]
2. Human a-L-fucosidase-1 attenuates the invasive properties of thyroid cancer.
Vecchio G; Parascandolo A; Allocca C; Ugolini C; Basolo F; Moracci M; Strazzulli A; Cobucci-Ponzano B; Laukkanen MO; Castellone MD; Tsuchida N
Oncotarget; 2017 Apr; 8(16):27075-27092. PubMed ID: 28404918
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of α-L-fucosidase 1 expression confers inferior survival for triple-negative breast cancer patients by modulating the glycosylation status of the tumor cell surface.
Cheng TC; Tu SH; Chen LC; Chen MY; Chen WY; Lin YK; Ho CT; Lin SY; Wu CH; Ho YS
Oncotarget; 2015 Aug; 6(25):21283-300. PubMed ID: 26204487
[TBL] [Abstract][Full Text] [Related]
4. Bxy-fuca encoding α-L-fucosidase plays crucial roles in development and reproduction of the pathogenic pinewood nematode, Bursaphelenchus xylophilus.
Tang J; Ma R; Zhu N; Guo K; Guo Y; Bai L; Yu H; Hu J; Zhang X
Pest Manag Sci; 2020 Jan; 76(1):205-214. PubMed ID: 31140718
[TBL] [Abstract][Full Text] [Related]
5. PI3K/AKT Signaling in Breast Cancer Molecular Subtyping and Lymph Node Involvement.
Bonin S; Pracella D; Barbazza R; Dotti I; Boffo S; Stanta G
Dis Markers; 2019; 2019():7832376. PubMed ID: 31781306
[TBL] [Abstract][Full Text] [Related]
6. Lymph node involvement in immunohistochemistry-based molecular classifications of breast cancer.
Howland NK; Driver TD; Sedrak MP; Wen X; Dong W; Hatch S; Eltorky MA; Chao C
J Surg Res; 2013 Dec; 185(2):697-703. PubMed ID: 24095025
[TBL] [Abstract][Full Text] [Related]
7. Plasma alpha-L-fucosidase activity in chronic inflammation and autoimmune disorders in a pediatric cohort of hospitalized patients.
Endreffy I; Bjørklund G; Szerafin L; Chirumbolo S; Urbina MA; Endreffy E
Immunol Res; 2017 Oct; 65(5):1025-1030. PubMed ID: 28808940
[TBL] [Abstract][Full Text] [Related]
8. CXCR4/CXCL12 Signaling and Protumor Macrophages in Primary Tumors and Sentinel Lymph Nodes Are Involved in Luminal B Breast Cancer Progression.
Raschioni C; Bottai G; Sagona A; Errico V; Testori A; Gatzemeier W; Corsi F; Tinterri C; Roncalli M; Santarpia L; Di Tommaso L
Dis Markers; 2018; 2018():5018671. PubMed ID: 29849822
[TBL] [Abstract][Full Text] [Related]
9. Association between molecular subtypes and lymph node status in invasive breast cancer.
Si C; Jin Y; Wang H; Zou Q
Int J Clin Exp Pathol; 2014; 7(10):6800-6. PubMed ID: 25400761
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of laminin-5 in breast carcinoma cells.
Martin KJ; Kwan CP; Nagasaki K; Zhang X; O'Hare MJ; Kaelin CM; Burgeson RE; Pardee AB; Sager R
Mol Med; 1998 Sep; 4(9):602-13. PubMed ID: 9848077
[TBL] [Abstract][Full Text] [Related]
11. The significance of extracapsular extension of axillary lymph node metastases in early-stage breast cancer.
Hetelekidis S; Schnitt SJ; Silver B; Manola J; Bornstein BA; Nixon AJ; Recht A; Gelman R; Harris JR; Connolly JL
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):31-4. PubMed ID: 10656369
[TBL] [Abstract][Full Text] [Related]
12. Plasma α-L-fucosidase-1 in patients with Sjögren's syndrome and other rheumatic disorders.
Endreffy I; Bjørklund G; Bartha A; Chirumbolo S; Dadar M; Fényi Á
Int J Rheum Dis; 2019 Sep; 22(9):1762-1767. PubMed ID: 31419081
[TBL] [Abstract][Full Text] [Related]
13. Coexisting ductal carcinoma in situ independently predicts lower tumor aggressiveness in node-positive luminal breast cancer.
Wong H; Lau S; Leung R; Chiu J; Cheung P; Wong TT; Liang R; Epstein RJ; Yau T
Med Oncol; 2012 Sep; 29(3):1536-42. PubMed ID: 21983862
[TBL] [Abstract][Full Text] [Related]
14. The prognostic value of lymph node status among breast cancer subtypes.
Liao GS; Chou YC; Hsu HM; Dai MS; Yu JC
Am J Surg; 2015 Apr; 209(4):717-24. PubMed ID: 25192588
[TBL] [Abstract][Full Text] [Related]
15. [Clinicopathological characteristics and prognosis of different molecular types of breast cancer].
Liu ZF; Chen C; Yao XL; Sun SR
Zhonghua Yi Xue Za Zhi; 2016 Jun; 96(22):1733-7. PubMed ID: 27356638
[TBL] [Abstract][Full Text] [Related]
16. FUCA1 is induced by wild-type p53 and expressed at different levels in thyroid cancers depending on p53 status.
Tsuchida N; Ikeda MA; Ιshino Υ; Grieco M; Vecchio G
Int J Oncol; 2017 Jun; 50(6):2043-2048. PubMed ID: 28440416
[TBL] [Abstract][Full Text] [Related]
17. Identification of a mutation in the structural alpha-L-fucosidase gene in fucosidosis.
Willems PJ; Darby JK; DiCioccio RA; Nakashima P; Eng C; Kretz KA; Cavalli-Sforza LL; Shooter EM; O'Brien JS
Am J Hum Genet; 1988 Nov; 43(5):756-63. PubMed ID: 2903668
[TBL] [Abstract][Full Text] [Related]
18. Restriction analysis of the structural alpha-L-fucosidase gene and its linkage to fucosidosis.
Darby JK; Willems PJ; Nakashima P; Johnsen J; Ferrell RE; Wijsman EM; Gerhard DS; Dracopoli NC; Housman D; Henke J
Am J Hum Genet; 1988 Nov; 43(5):749-55. PubMed ID: 2903667
[TBL] [Abstract][Full Text] [Related]
19. St Gallen molecular subtypes in primary breast cancer and matched lymph node metastases--aspects on distribution and prognosis for patients with luminal A tumours: results from a prospective randomised trial.
Falck AK; Fernö M; Bendahl PO; Rydén L
BMC Cancer; 2013 Nov; 13():558. PubMed ID: 24274821
[TBL] [Abstract][Full Text] [Related]
20. Triple-negative breast cancer is not associated with increased likelihood of nodal metastases.
Gangi A; Mirocha J; Leong T; Giuliano AE
Ann Surg Oncol; 2014 Dec; 21(13):4098-103. PubMed ID: 25155393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
